Efficacy and safety of artesunate–amodiaquine and artemether–lumefantrine and prevalence of molecular markers associated with resistance, Guinea: an open-label two-arm randomised controlled trial

被引：0
作者：
Abdoul Habib Beavogui
Alioune Camara
Alexandre Delamou
Mamadou Saliou Diallo
Abdoulaye Doumbouya
Karifa Kourouma
Patrice Bouedouno
Timothée Guilavogui
Samaly dos Santos Souza
Julia Kelley
Eldin Talundzic
Aissata Fofana
Mateusz M. Plucinski
机构：
[1] Centre National de Formation et de Recherche en Santé Rurale de Maferinyah,Department of Medical Sciences
[2] Gamal Abdel Nasser University,Centre d’Excellence Africain pour la Prévention et le Contrôle des Maladies Transmissibles (CEA
[3] Gamal Abdel Nasser University,PCMT)
[4] Gamal Abdel Nasser University,Department of Public Health
[5] National Malaria Control Programme,Malaria Branch
[6] Direction of Epidemiology,Atlanta Research and Education Foundation and Malaria Branch
[7] Ministry of Health,Malaria Branch and U.S. President’s Malaria Initiative
[8] Centers for Disease Control and Prevention,undefined
[9] Centers for Disease Control and Prevention,undefined
[10] RTI International,undefined
[11] Centers for Disease Control and Prevention,undefined
来源：
Malaria Journal | / 19卷
关键词：
Efficacy; Artesunate–amodiaquine; Artemether–lumefantrine; Molecular makers; Guinea;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 189 条
  • [1] Snow RW(2017)The prevalence of Nature 550 515-423
  • [2] Sartorius B(2014) in sub Saharan Africa since 1900 N Engl J Med 371 411-1142
  • [3] Kyalo D(2019)Spread of artemisinin resistance in PLoS ONE 14 e0222379-443
  • [4] Maina J(2018) malaria Malar J. 17 369-14
  • [5] Amratia P(2018)Safety and tolerability of artesunate–amodiaquine, artemether–lumefantrine and quinine plus clindamycin in the treatment of uncomplicated Malar J. 17 144-1390
  • [6] Mundia CW(2016) malaria in Kinshasa, the Democratic Republic of the Congo J Infect Dis 213 1134-773
  • [7] Ashley EA(2019)Efficacy and safety of artemisinin-based combination therapy, and molecular markers for artemisinin and piperaquine resistance in mainland Tanzania Malar J. 18 88-44
  • [8] Dhorda M(2015)Efficacy and safety of artemether–lumefantrine, artesunate–amodiaquine, and dihydroartemisinin–piperaquine for the treatment of uncomplicated Antimicrob Agents Chemother 59 437-1406
  • [9] Fairhurst RM(2016) malaria in three provinces in Angola, 2017 Malar J. 15 74-404
  • [10] Amaratunga C(2019)Artesunate/amodiaquine versus artemether/lumefantrine for the treatment of uncomplicated malaria in Uganda: a randomized trial Malar J. 18 424-6100
12345678910